Select Publications
Journal articles
2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ (Online), 355, http://dx.doi.org/10.1136/bmj.i5599
,2016, 'Long-term outcomes of end-stage kidney disease for patients with lupus nephritis', Kidney International, 89, pp. 1337 - 1345, http://dx.doi.org/10.1016/j.kint.2016.02.014
,2016, 'MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', Nephrology Dialysis Transplantation, 31, pp. i413 - i413, http://dx.doi.org/10.1093/ndt/gfw187.27
,2015, 'The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: A sub-study of the Honeypot trial', Peritoneal Dialysis International, 35, pp. 712 - 721, http://dx.doi.org/10.3747/pdi.2014.00206
,2015, 'End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy-Outcomes in 66 consecutive ANZDATA registry cases', American Journal of Nephrology, 42, pp. 177 - 184, http://dx.doi.org/10.1159/000440815
,2015, 'DISPARITIES IN SURVIVAL OF DIALYSIS PATIENTS IN AUSTRALIA BASED UPON ETHNICITY AND COUNTRY OF BIRTH', NEPHROLOGY, 20, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AND CLINICAL OUTCOMES IN ADULT KIDNEY TRANSPLANT RECIPIENTS', NEPHROLOGY, 20, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial', Canadian Journal of Kidney Health and Disease, 2, http://dx.doi.org/10.1186/s40697-015-0066-5
,2015, 'Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, 35, pp. 450 - 459, http://dx.doi.org/10.3747/pdi.2013.00004
,2015, 'The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: The updated final trial protocol and rationale of post-initiation trial modifications', BMC Nephrology, 16, http://dx.doi.org/10.1186/s12882-015-0089-2
,2015, 'A nephrology guide to reading and using systematic reviews of randomized trials', Nephrology Dialysis Transplantation, 30, pp. 878 - 884, http://dx.doi.org/10.1093/ndt/gfu222
,2015, 'The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study', Nephrology, 20, pp. 140 - 147, http://dx.doi.org/10.1111/nep.12362
,2015, 'The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 35, pp. 222 - 228, http://dx.doi.org/10.3747/pdi.2013.00156
,2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial', American Journal of Kidney Diseases, 65, pp. 49 - 57, http://dx.doi.org/10.1053/j.ajkd.2014.06.020
,2015, 'Daily home hemodialysis: Balancing cardiovascular benefits with infectious harms', American Journal of Kidney Diseases, 65, pp. 6 - 8, http://dx.doi.org/10.1053/j.ajkd.2014.08.012
,2015, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews
,2014, 'The association between body mass index and mortality in incident dialysis patients', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0114897
,2014, 'End-stage kidney disease due to alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases', Nephrology Dialysis Transplantation, 29, pp. 2277 - 2286, http://dx.doi.org/10.1093/ndt/gfu254
,2014, 'Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis', Nephrology Dialysis Transplantation, 29, pp. 1940 - 1947, http://dx.doi.org/10.1093/ndt/gfu050
,2014, 'A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL', NEPHROLOGY, 19, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS', NEPHROLOGY, 19, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'MICROBIOLOGICAL RESULTS OF THE HONEYPOT STUDY - SECONDARY ANALYSIS OF A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS', NEPHROLOGY, 19, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL', NEPHROLOGY, 19, pp. 35 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 29, pp. 406 - 413, http://dx.doi.org/10.1093/ndt/gft378
,2014, 'Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial', The Lancet Infectious Diseases, 14, pp. 23 - 30, http://dx.doi.org/10.1016/S1473-3099(13)70258-5
,2014, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2014, http://dx.doi.org/10.1002/14651858.CD007554.pub2
,2014, 'Biocompatible dialysis fluids for peritoneal dialysis.', The Cochrane database of systematic reviews, 3
,2014, 'Chronic kidney disease: haemodialysis catheter care in practice.', Nature reviews. Nephrology, 10, pp. 131 - 133, http://dx.doi.org/10.1038/nrneph.2014.3
,2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, 85, pp. 23 - 30, http://dx.doi.org/10.1038/ki.2013.391
,2014, 'The association between peritoneal dialysis modality and peritonitis', Clinical Journal of the American Society of Nephrology, 9, pp. 1091 - 1097, http://dx.doi.org/10.2215/CJN.09730913
,2014, 'The role of monitoring Gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 34, pp. 219 - 226, http://dx.doi.org/10.3747/pdi.2012.00318
,2013, 'Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes', Clinical Journal of the American Society of Nephrology, 8, pp. 1556 - 1563, http://dx.doi.org/10.2215/CJN.12361212
,2013, 'A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS - HONEYPOT STUDY', NEPHROLOGY, 18, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD006861.pub3
,2013, 'Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials', Nephrology Dialysis Transplantation, 28, pp. 1899 - 1907, http://dx.doi.org/10.1093/ndt/gft050
,2013, 'The honeypot randomized controlled trial statistical analysis plan', Peritoneal Dialysis International, 33, pp. 426 - 435, http://dx.doi.org/10.3747/pdi.2012.00310
,2013, 'The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand', Clinical Journal of the American Society of Nephrology, 8, pp. 773 - 780, http://dx.doi.org/10.2215/CJN.08770812
,2013, 'End-stage renal failure due to amyloidosis: Outcomes in 490 ANZDATA registry cases', Nephrology Dialysis Transplantation, 28, pp. 455 - 461, http://dx.doi.org/10.1093/ndt/gfs492
,2013, 'Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease', Kidney International, 83, pp. 503 - 510, http://dx.doi.org/10.1038/ki.2012.375
,2013, 'Daily variation in death in patients treated by long-term dialysis: Comparison of in-center hemodialysis to peritoneal and home hemodialysis', American Journal of Kidney Diseases, 61, pp. 96 - 103, http://dx.doi.org/10.1053/j.ajkd.2012.07.008
,2013, 'Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: A multicenter registry study', Peritoneal Dialysis International, 33, pp. 75 - 85, http://dx.doi.org/10.3747/pdi.2011.00317
,2013, 'The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients', Kidney International, 84, pp. 969 - 979, http://dx.doi.org/10.1038/ki.2013.190
,2012, 'End-stage kidney disease due to haemolytic uraemic syndrome - Outcomes in 241 consecutive ANZDATA registry cases', BMC Nephrology, 13, http://dx.doi.org/10.1186/1471-2369-13-164
,2012, 'Biocompatible peritoneal dialysis fluids: Clinical outcomes', International Journal of Nephrology, 2012, http://dx.doi.org/10.1155/2012/812609
,2012, 'Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 32, pp. 516 - 524, http://dx.doi.org/10.3747/pdi.2011.00169
,2012, 'NXSTAGE QUEENSLAND HEALTH PILOT PROGRAM THE EARLY AUSTRALIAN NXSTAGE EXPERIENCE: IS NXSTAGE REALLY THE NEXT STAGE IN HOME HAEMODIALYSIS?', NEPHROLOGY, 17, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'TWO CASES OF ATYPICAL HAEMOLYTIC UREMIC SYNDROME TREATED WITH ECULIZUMAB', NEPHROLOGY, 17, pp. 91 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: A multi-centre registry study', BMC Nephrology, 13, http://dx.doi.org/10.1186/1471-2369-13-41
,2012, 'A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation', Transplantation, 93, pp. 822 - 826, http://dx.doi.org/10.1097/TP.0b013e318248375a
,2012, 'Overexpression of RAD51 promotes brain metastases from breast cancer', CANCER RESEARCH, 72, http://dx.doi.org/10.1158/1538-7445.AM2012-5306
,